The ThinkEquity Conference 2024
Princeton, NJ, October 24, 2024 - PRISM MediaWire - Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today ...

24 October 2024

News
BranchOut Peru Facility Now Operational, Driving Profitability Through High-Margin Production

24 October 2024

The ThinkEquity Conference 2024
Glen Allen, VA, October 23, 2024 - PRISM MediaWire - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, tod...

23 October 2024

The ThinkEquity Conference 2024
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

23 October 2024

The ThinkEquity Conference 2024
Presentation on October 30 at 4 p.m. ET, and Attend 1x1 Meetings

23 October 2024

News
Discoverer of Klotho gene further strengths KLTO Scientific Advisory Board

23 October 2024

News
Jointly Initiating First Coal Shipment Utilizing Bloxcross’ Proprietary Trade Finance Platform

22 October 2024

News
Hauppauge, NY, October 22, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including th...

22 October 2024

The ThinkEquity Conference 2024
NEW YORK, October 21, 2024 – PRISM MediaWire - PRISM MarketView is proud to announce its role as the official media sponsor for the upcoming ThinkEquity Conference, a premier event bringing together investors, innovators and industry leaders. The conference will be held ...

21 October 2024

The ThinkEquity Conference 2024
Herzliya, Israel and Calgary, Alberta, October 21, 2024 - PRISM MediaWire - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will b...

21 October 2024

1
2
3
4
5
6
7
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.